Article

Steroids Reduce Signs of Aortic Aneurysm Risk in GCA

In a before-and-after study with CT imaging, signs of large vessel vasculitis and aortic wall thickening improved for some but not all patients treated with steroids for giant-cell arteritis

Prieto-González S; García-Martínez A, Tavera-Bahillo I, et al.Effect of Glucocorticoid Treatment on Computed Tomography Angiography Detected Large-Vessel Inflammation in Giant-Cell Arteritis. A Prospective, Longitudinal Study. Medicine. 2015; 94(5):e486doi: 10.1097/MD.0000000000000486

This report extends recent imaging studies on the newly identified inflammation of the aorta and its branches in giant-cell arteritis (GCA).

GCA has an increased risk of thoracic aortic aneurysm, but it is not known whether the inflammation directly causes the aneurysm or whether treating the inflammation will reduce the risk.

This study evaluated signs of large-vessel inflammation and remodeling of the aorta after a year of treatment with glucocorticoids.

Forty biopsy-proven GCA patients were prospectively evaluated by computed tomography angiography (CTA) for vessel wall thickening, diameter, and contrast enhancement of the aorta and its tributaries at diagnosis. CTA was repeated one year later on 35 patients.

Signs of large vessel vasculitis improved with treatment. Wall thickness along the aorta, measured at the ascending arch and the descending and abdominal aorta, was reduced in some patients, but persisted in two-thirds. Contrast enhancement resolved in most patients.

The number of affected segments and wall thickness significantly deceased, and no patients developed new lesions.

Notably, there were no significant differences in aortic diameters.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.